1. Home
  2. HEPA vs WORX Comparison

HEPA vs WORX Comparison

Compare HEPA & WORX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HEPA
  • WORX
  • Stock Information
  • Founded
  • HEPA 2013
  • WORX N/A
  • Country
  • HEPA United States
  • WORX United States
  • Employees
  • HEPA N/A
  • WORX N/A
  • Industry
  • HEPA Biotechnology: Pharmaceutical Preparations
  • WORX Services-Misc. Amusement & Recreation
  • Sector
  • HEPA Health Care
  • WORX Consumer Discretionary
  • Exchange
  • HEPA Nasdaq
  • WORX Nasdaq
  • Market Cap
  • HEPA 4.1M
  • WORX 3.4M
  • IPO Year
  • HEPA N/A
  • WORX N/A
  • Fundamental
  • Price
  • HEPA $0.47
  • WORX $1.80
  • Analyst Decision
  • HEPA
  • WORX
  • Analyst Count
  • HEPA 0
  • WORX 0
  • Target Price
  • HEPA N/A
  • WORX N/A
  • AVG Volume (30 Days)
  • HEPA 100.9K
  • WORX 57.7K
  • Earning Date
  • HEPA 11-14-2024
  • WORX 11-14-2024
  • Dividend Yield
  • HEPA N/A
  • WORX N/A
  • EPS Growth
  • HEPA N/A
  • WORX N/A
  • EPS
  • HEPA N/A
  • WORX N/A
  • Revenue
  • HEPA N/A
  • WORX $3,224,146.00
  • Revenue This Year
  • HEPA N/A
  • WORX N/A
  • Revenue Next Year
  • HEPA N/A
  • WORX N/A
  • P/E Ratio
  • HEPA N/A
  • WORX N/A
  • Revenue Growth
  • HEPA N/A
  • WORX N/A
  • 52 Week Low
  • HEPA $0.43
  • WORX $0.75
  • 52 Week High
  • HEPA $3.49
  • WORX $4.44
  • Technical
  • Relative Strength Index (RSI)
  • HEPA 42.44
  • WORX 52.47
  • Support Level
  • HEPA $0.43
  • WORX $1.66
  • Resistance Level
  • HEPA $0.53
  • WORX $1.88
  • Average True Range (ATR)
  • HEPA 0.07
  • WORX 0.18
  • MACD
  • HEPA -0.01
  • WORX -0.00
  • Stochastic Oscillator
  • HEPA 13.36
  • WORX 48.96

About HEPA Hepion Pharmaceuticals Inc.

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

Share on Social Networks: